Pharma company ICON has reported net revenues of $394.7m for the third quarter to the end of September, up 1.8% on the $387.5m the same time last year.
ICON said that income from operations increased by 20.1% to $71.4m in the three month period.
The company said its net income increased by 22% to $61.5m or $1.02 per share on a diluted basis, compared with $50.3m or $0.79 per share for the same time last year.
Founded in 1990, ICON provides outsourced development services to the pharmaceutical, biotech and medical device industries worldwide.
Headquartered in Dublin, it operates from 77 locations in 38 countries and has about 11,700 employees. It has about 1,000 Irish workers.
In its results release, ICON also reported net new business wins of $475m and said it grew its backlog by 8% over last year.
